JPY 575.0
(-0.69%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 418.88 Billion JPY | 25.15% |
2022 | 334.71 Billion JPY | 24.41% |
2021 | 269.04 Billion JPY | -1.74% |
2020 | 273.81 Billion JPY | -8.11% |
2019 | 297.98 Billion JPY | 863.09% |
2018 | 30.94 Billion JPY | -34.73% |
2017 | 47.4 Billion JPY | -30.29% |
2016 | 68 Billion JPY | 33.31% |
2015 | 51.01 Billion JPY | -41.04% |
2014 | 86.52 Billion JPY | -8.92% |
2013 | 95 Billion JPY | -17.39% |
2012 | 115 Billion JPY | -10.16% |
2011 | 128 Billion JPY | -16.67% |
2010 | 153.6 Billion JPY | -7.36% |
2009 | 165.8 Billion JPY | 0.0% |
2008 | - JPY | -100.0% |
2007 | 4.6 Billion JPY | -19.3% |
2006 | 5.7 Billion JPY | -26.54% |
2005 | 7.75 Billion JPY | -2.65% |
2004 | 7.97 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 390.07 Billion JPY | -6.88% |
2024 Q2 | 389.38 Billion JPY | -0.18% |
2023 FY | 418.88 Billion JPY | 25.15% |
2023 Q2 | 383.8 Billion JPY | 3.23% |
2023 Q3 | 411.84 Billion JPY | 7.31% |
2023 Q4 | 418.88 Billion JPY | 1.71% |
2023 Q1 | 371.78 Billion JPY | 11.08% |
2022 Q2 | 249.71 Billion JPY | -7.14% |
2022 Q1 | 268.91 Billion JPY | -0.05% |
2022 FY | 334.71 Billion JPY | 24.41% |
2022 Q4 | 334.71 Billion JPY | 34.04% |
2022 Q3 | 249.71 Billion JPY | 0.0% |
2021 Q3 | 269.75 Billion JPY | -0.25% |
2021 Q4 | 269.04 Billion JPY | -0.26% |
2021 FY | 269.04 Billion JPY | -1.74% |
2021 Q1 | 273.14 Billion JPY | -0.24% |
2021 Q2 | 270.42 Billion JPY | -1.0% |
2020 Q3 | 294.52 Billion JPY | -0.98% |
2020 Q2 | 297.43 Billion JPY | 0.06% |
2020 FY | 273.81 Billion JPY | -8.11% |
2020 Q1 | 297.24 Billion JPY | -0.25% |
2020 Q4 | 273.81 Billion JPY | -7.03% |
2019 FY | 297.98 Billion JPY | 863.09% |
2019 Q4 | 297.98 Billion JPY | -1.82% |
2019 Q3 | 303.49 Billion JPY | 930.18% |
2019 Q2 | 29.46 Billion JPY | -2.45% |
2019 Q1 | 30.2 Billion JPY | -2.39% |
2018 Q1 | 46.66 Billion JPY | -1.56% |
2018 Q4 | 30.94 Billion JPY | -2.34% |
2018 Q3 | 31.68 Billion JPY | -2.28% |
2018 FY | 30.94 Billion JPY | -34.73% |
2018 Q2 | 32.42 Billion JPY | -30.52% |
2017 Q2 | 60 Billion JPY | -11.76% |
2017 Q1 | 68 Billion JPY | 0.0% |
2017 FY | 47.4 Billion JPY | -30.29% |
2017 Q4 | 47.4 Billion JPY | -20.07% |
2017 Q3 | 59.3 Billion JPY | -1.17% |
2016 Q4 | 68 Billion JPY | 0.0% |
2016 Q1 | 50.92 Billion JPY | -0.17% |
2016 Q2 | 28 Billion JPY | -45.01% |
2016 FY | 68 Billion JPY | 33.31% |
2016 Q3 | 68 Billion JPY | 142.86% |
2015 Q2 | 81.85 Billion JPY | -2.15% |
2015 FY | 51.01 Billion JPY | -41.04% |
2015 Q3 | 81.45 Billion JPY | -0.49% |
2015 Q4 | 51.01 Billion JPY | -37.37% |
2015 Q1 | 83.65 Billion JPY | -3.31% |
2014 Q3 | 89.39 Billion JPY | -1.0% |
2014 Q2 | 90.29 Billion JPY | -2.69% |
2014 Q1 | 92.79 Billion JPY | -2.32% |
2014 FY | 86.52 Billion JPY | -8.92% |
2014 Q4 | 86.52 Billion JPY | -3.21% |
2013 Q1 | 112.5 Billion JPY | -2.17% |
2013 Q3 | 107.5 Billion JPY | -2.27% |
2013 FY | 95 Billion JPY | -17.39% |
2013 Q4 | 95 Billion JPY | -11.63% |
2013 Q2 | 110 Billion JPY | -2.22% |
2012 FY | 115 Billion JPY | -10.16% |
2012 Q2 | 123 Billion JPY | -1.99% |
2012 Q3 | 120.5 Billion JPY | -2.03% |
2012 Q1 | 125.5 Billion JPY | -1.95% |
2012 Q4 | 115 Billion JPY | -4.56% |
2011 FY | 128 Billion JPY | -16.67% |
2011 Q1 | 143.5 Billion JPY | -6.58% |
2011 Q3 | 130.5 Billion JPY | -1.88% |
2011 Q2 | 133 Billion JPY | -7.32% |
2011 Q4 | 128 Billion JPY | -1.92% |
2010 Q3 | 156.1 Billion JPY | -2.98% |
2010 Q4 | 153.6 Billion JPY | -1.6% |
2010 Q2 | 160.9 Billion JPY | -3.31% |
2010 Q1 | 166.4 Billion JPY | 0.36% |
2010 FY | 153.6 Billion JPY | -7.36% |
2009 Q3 | 204.25 Billion JPY | 22595.11% |
2009 FY | 165.8 Billion JPY | 0.0% |
2009 Q4 | 165.8 Billion JPY | -18.83% |
2009 Q2 | 900 Million JPY | 0.0% |
2008 Q4 | - JPY | 0.0% |
2008 FY | - JPY | -100.0% |
2007 FY | 4.6 Billion JPY | -19.3% |
2006 FY | 5.7 Billion JPY | -26.54% |
2005 FY | 7.75 Billion JPY | -2.65% |
2004 FY | 7.97 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -2379.924% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 91.352% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -3504.854% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -416579.764% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -14485.097% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -10780.104% |
Eisai Co., Ltd. | 206.74 Billion JPY | -102.608% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -98460.941% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -19846.857% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -113418.699% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -3192.596% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -2366.781% |
Tsumura & Co. | 79.69 Billion JPY | -425.642% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -24155.009% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -171573.77% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | -107.003% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -1347.022% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | -780.269% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | -1899.828% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -10897.217% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -4704.267% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -698040.0% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -101447.636% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -4316.278% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | -405.349% |
Cyfuse Biomedical K.K. | 913 Million JPY | -45779.956% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | -1285.015% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -14726.241% |